hIL9 Effector Reporter Cell
CBP74207
詢(xún) 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. Background | |
| IL9 (Interleukin 9) is a Protein Coding gene. Diseases associated with IL9 include Severe Combined Immunodeficiency, X-Linked and Trichuriasis. Among its related pathways are Apoptotic Pathways in Synovial Fibroblasts and MIF Mediated Glucocorticoid Regulation. | |
| II.Introduction | |
| Expressed gene: | IL9R |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10%DMSO |
| Culture Medium: | DMEM+10%FBS+2μg/ml Puromycin+100μg/ml Hygromycin B+5μg/ml Blasticidin+400μg/ml G418 |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
|
Figure 1. Recombinant hIL9 Effector Reporter Cell constitutively expressing CD132.
Figure 2. Recombinant hIL9 Effector Reporter Cell constitutively expressing IL9R. |
|
|
Figure 3. Dose Response of Recombinant Human IL9 in hIL9 Effector Reporter Cells (C18) |
|
|
Figure 4.Inhibition of Human IL9-induced Reporter Activity by hIL9 Neutralization Ab in hIL9 Effector Reporter Cells (C18). |
|
